Common adverse events and side effects Tirzepatide may cause common side effects in irritable bowel syndrome, such as diarrhea, constipation, nausea, vomiting, upper abdominal discomfort, decreased appetite, and abdominal pain
Mearns ES, Saulsberry WJ, White CM et al (2015) Efficacy and safety of antihyperglycaemic drug regimens added to metformin and sulphonylurea therapy in type 2 diabetes: a network meta-analysis
Alli-Oluwafuyi AM, Luis PB, Nakashima F, et
Store lyophilized MT-1 at -20C protected from light
[PMID: 28864898] PubMed record related to this compound for laboratory literature review
Track the whole GLP-1 field I keep a running tracker of every GLP-1 and incretin drug, approved and still in the pipeline, with what each one targets, how far along it is, and what's coming next